 weaker
Grade 2 guidelines.
Although trial methodology is related to the quality of
the evidence, clinicians are actually most interested in reliable estimates of the benefits and harms associated with a
therapy.21 For high-quality evidence, the effects of therapy
(beneficial or ill) are precise, and further research is unlikely
to change our confidence in the estimate of effect. In
contrast, the estimated effect provided by poor-quality
evidence is unclear and likely to change as better quality
